Redox control of platelet function

Antioxidants and Redox Signaling

Volumn 11, Issue 5, 2009, Pages 1191-1225

  Essex, David W ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; ACTIN; ADENOSINE DIPHOSPHATE; CYTOPLASM PROTEIN; FIBRONECTIN; GLUTATHIONE; GLYCOPROTEIN IB; GLYCOPROTEIN VI; INTEGRIN; INTEGRIN ALPHA 2BBETA 3; MEMBRANE PROTEIN; NITRIC OXIDE; PEROXYNITRITE; PROTEIN DISULFIDE ISOMERASE; PROTEIN TYROSINE PHOSPHATASE 1B; PURINERGIC P2Y12 RECEPTOR; REACTIVE OXYGEN METABOLITE; THIOL DERIVATIVE; THIOSULFATE; THROMBOCYTE RECEPTOR; THROMBOSPONDIN 1; THROMBOXANE; UNCLASSIFIED DRUG; VITRONECTIN; PDIA6 PROTEIN, HUMAN; PLASMA PROTEIN;

ALLOSTERISM; CELL ADHESION; DIMERIZATION; DISULFIDE BOND; MUTATIONAL ANALYSIS; NITROSYLATION; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN FUNCTION; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; ANIMAL; CYTOLOGY; HUMAN; METABOLISM; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; BLOOD PROTEINS; HUMANS; OXIDATION-REDUCTION; PROTEIN DISULFIDE-ISOMERASES; SULFHYDRYL COMPOUNDS;

EID: 64549119138     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2008.2322     Document Type: Review

References (294)

1. Abrams CS and Brass LF. Platelet signal transduction. In: Hemostasis and Thrombosis Basic Principles and Clinical Practice, edited by Colman RW, Clowes AW, Goldhaber SZ, Marder VJ and George JN. Philadelphia, PA: Lippincott Williams & Wilkins, 2006, p. 617-632.
2. Ahamed J, Burg N, Yoshinaga K, Janczak CA, Rifkin DB, and Coller BS. In vitro and in vivo evidence for shearinduced activation of latent transforming growth factor- {beta}1 (TGF-{beta}1). Blood 112: 3650-3660, 2008.
3. Ahamed J, Versteeg HH, Kerver M, Chen VM, Mueller BM, Hogg PJ, and Ruf W. Disulfide isomerization switches tissue factor from coagulation to cell signaling. Proc Natl Acad Sci USA 103: 13932-13937, 2006.
4. Akhter S, Vignini A, Wen Z, English A, Wang PG, and Mutus B. Evidence for S-nitrosothiol-dependent changes in fibrinogen that do not involve transnitrosation or thiolation. Proc Natl Acad Sci USA 99: 9172-9177, 2002.
5. Aledort LM, Troup SB, and Weed RI. Inhibition of sulfhydryl-dependent platelet functions by penetrating and non-penetrating analogues of parachloromercuribenzene. Blood 31: 471-479, 1968.
6. Anderson ME and Meister A. Dynamic state of glutathione in blood plasma. J Biol Chem 255: 9530-9533, 1980.
7. Andersson A, Isaksson A, Brattstrom L, and Hultberg B. Homocysteine and other thiols determined in plasma by HPLC and thiol-specific postcolumn derivatization. Clin Chem 39: 1590-1597, 1993.
8. Ando Y and Steiner M. Distribution of free sulfhydryl and disulfide groups among platelet membrane proteins. Biochim Biophys Acta 419: 51-62, 1976.
9. Ando Y and Steiner M. Sulfhydryl and disulfide groups of platelet membranes. II. Determination of disulfide groups. Biochim Biophys Acta 311: 38-44, 1973.
10. Arias-Salgado EG, Haj F, Dubois C, Moran B, Kasirer- Friede A, Furie BC, Furie B, Neel BG, and Shattil SJ. PTP-1B is an essential positive regulator of platelet integrin signaling. J Cell Biol 170: 837-845, 2005.
11. Arnaout MA, Goodman SL, and Xiong JP. Coming to grips with integrin binding to ligands. Curr Opin Cell Biol 14: 641-651, 2002.
12. Arthur JF, Gardiner EE, Kenny D, Andrews RK, and Berndt MC. Platelet receptor redox regulation. Platelets 19: 1-8, 2008.
13. Arthur JF, Shen Y, Kahn ML, Berndt MC, Andrews RK, and Gardiner EE. Ligand binding rapidly induces disulfidedependent dimerization of glycoprotein VI on the platelet plasma membrane. J Biol Chem 282: 30434-30441, 2007.
14. Asch E and Podack E. Vitronectin binds to activated human platelets and plays a role in platelet aggregation. J Clin Invest 85: 1372-1378, 1990.
15. Babior BM. NADPH oxidase: An update. Blood 93: 1464- 1476, 1999.
16. Badol P, David-Dufilho M, Auger J, Whiteheart SW, and Rendu F. Thiosulfinates modulate platelet activation by reaction with surface free sulfhydryls and internal thiolcontaining proteins. Platelets 18: 481-490, 2007.
17. Ball C, Vijayan K., Bray PF, Essex DW, and Dong J. Glutathione regulation of integrin αIIb β3-mediated cell adhesion under flow conditions. Thromb Haemost 100: 857- 863, 2008.
18. Banno A and Ginsberg MH. Integrin activation. Biochem Soc Trans 36: 229-234, 2008.
19. Barbouche R, Miquelis R, Jones IM, and Fenouillet E. Protein-disulfide isomerase-mediated reduction of two disulfide bonds of HIV envelope glycoprotein 120 occurs post-CXCR4 binding and is required for fusion. J Biol Chem 278: 3131-3136, 2003.
20. Beglova N, Blacklow SC, Takagi J, and Springer TA. Cysteine-rich module structure reveals a fulcrum for integrin rearrangement upon activation. Nat Struct Biol 9: 282-287, 2002.
21. Begonja AJ, Gambaryan S, Geiger J, Aktas B, Pozgajova M, Nieswandt B, and Walter U. Platelet NAD(P)H-oxidasegenerated ROS production regulates αIIbβ3-integrin activation independent of the NO/cGMP pathway. Blood 106: 2757-2760, 2005.
22. Bell SE, Shah CM, and Gordge MP. Protein disulfideisomerase mediates delivery of nitric oxide redox derivatives into platelets. Biochem J 403: 283-288, 2007.
23. Bennett TA, Edwards BS, Sklar LA, and Rogelj S. Sulfhydryl regulation of L-selectin shedding: phenylarsine oxide promotes activation-independent L-selectin shedding from leukocytes. J Immunol 164: 4120-4129, 2000.
24. Berlett BS and Stadtman ER. Protein oxidation in aging, disease, and oxidative stress. J Biol Chem 272: 20313-20316, 1997.
25. Berridge MV and Tan AS. High-capacity redox control at the plasma membrane of mammalian cells: transmembrane, cell surface, and serum NADH-oxidases. Antioxid Redox Signal 2: 231-242, 2000.
26. Bonomini F, Tengattini S, Fabiano A, Bianchi R, and Rezzani R. Atherosclerosis and oxidative stress. Histol Histopathol 23: 381-390, 2008.
27. Booyse FM, Sternberger LA, Zschocke D, and Rafelson ME, Jr. Ultrastructural localization of contractile protein (thrombosthenin) in human platelets using an unlabeled antibody-peroxidase staining technique. J Histochem Cytochem 19: 540-550, 1971.
28. Bosia A, Spangenberg P, Losche W, Arese P, and Till U. The role of the GSH-disulfide status in the reversible and irreversible aggregation of human platelets. Thromb Res 30: 137-142, 1983.
29. Brown AS, Moro MA, Masse JM, Cramer EM, Radomski M, and Darley-Usmar V. Nitric oxide-dependent and independent effects on human platelets treated with peroxynitrite. Cardiovasc Res 40: 380-388, 1998.
30. Bruckdorfer KR. The nitration of proteins in platelets. C R Acad Sci III 324: 611-615, 2001.
31. Burgess JK, Hotchkiss KA, Suter C, Dudman NP, Szollosi J, Chesterman CN, Chong BH, and Hogg PJ. Physical proximity and functional association of glycoprotein 1bα and protein-disulfide isomerase on the platelet plasma membrane. J Biol Chem 275: 9758-9766, 2000.
32. Butta N, Arias-Salgado EG, Gonzalez-Manchon C, Ferrer M, Larrucea S, Ayuso MS, and Parrilla R. Disruption of the β3 663-687 disulfide bridge confers constitutive activity to β3 integrins. Blood 102: 2491-2497, 2003.
33. Calvete JJ and Gonzalez-Rodriguez J. Isolation and biochemical characterization of the alpha- and beta-subunits of glycoprotein IIb of human platelet plasma membrane. Biochem J 240: 155-161, 1986.
34. Calvete JJ, Henschen A, and Gonzalez-Rodriguez J. Assignment of disulphide bonds in human platelet GPIIIa. A disulphide pattern for the beta-subunits of the integrin family. Biochem J 274: 63-71, 1991.
35. Cambien B and Wagner DD. A new role in hemostasis for the adhesion receptor P-selectin. Trends Mol Med 10: 179- 186, 2004.
36. Carvalho AP, Fernandes PA, and Ramos MJ. Similarities and differences in the thioredoxin superfamily. Prog Biophys Mol Biol 91: 229-248, 2006.
37. Cavagnaro PF, Camargo A, Galmarini CR, and Simon PW. Effect of cooking on garlic (Allium sativum L.) antiplatelet activity and thiosulfinates content. J Agric Food Chem 55: 1280-1288, 2007.
38. Chakrabarti S, Clutton P, Varghese S, Cox D, Mascelli MA, and Freedman JE. Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release. Thromb Res 113: 225-233, 2004.
39. Chaudhuri AR, Khan IA, and Luduena RF. Detection of disulfide bonds in bovine brain tubulin and their role in protein folding and microtubule assembly in vitro: A novel disulfide detection approach. Biochemistry 40: 8834-8841, 2001.
40. Chen K, Detwiler TC, and Essex DW. Characterization of protein disulphide isomerase released from activated platelets. Br J Haematol 90: 425-431, 1995.
41. Chen K, Lin Y, and Detwiler TC. Protein disulfide isomerase activity is released by activated platelets. Blood 79: 2226-2228, 1992.
42. Chen P, Melchior C, Brons NH, Schlegel N, Caen J, and Kieffer N. Probing conformational changes in the I-like domain and the cysteine-rich repeat of human β 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in αIIbβ3 activation. J Biol Chem 276: 38628-38635, 2001.
43. Chen VM, Ahamed J, Versteeg HH, Berndt MC, Ruf W, and Hogg PJ. Evidence for activation of tissue factor by an allosteric disulfide bond. Biochemistry 45: 12020-12028, 2006.
44. Chen VM and Hogg PJ. Allosteric disulfide bonds in thrombosis and thrombolysis. J Thromb Haemost 4: 2533- 2541, 2006.
45. Chiarugi P, Fiaschi T, Taddei ML, Talini D, Giannoni E, Raugei G, and Ramponi G. Two vicinal cysteines confer a peculiar redox regulation to low molecular weight protein tyrosine phosphatase in response to platelet-derived growth factor receptor stimulation. J Biol Chem 276: 33478- 33487, 2001.
46. Chiarugi P, Pani G, Giannoni E, Taddei L, Colavitti R, Raugei G, Symons M, Borrello S, Galeotti T, and Ramponi G. Reactive oxygen species as essential mediators of cell adhesion: the oxidative inhibition of a FAK tyrosine phosphatase is required for cell adhesion. J Cell Biol 161: 933-944, 2003.
47. Cho J, Furie BC, Coughlin SR, and Furie B. A critical role for extracellular protein disulfide isomerase during thrombus formation in mice. J Clin Invest 118: 1123-1131, 2008.
48. Cho J and Mosher DF. Role of fibronectin assembly in platelet thrombus formation. J Thromb Haemost 4: 1461- 1469, 2006.
49. Choi H, Aboulfatova K, Pownall HJ, Cook R, and Dong JF. Shear-induced disulfide bond formation regulates adhesion activity of von Willebrand factor. J Biol Chem 282: 35604- 35611, 2007.
50. Choi J, Levey AI, Weintraub ST, Rees HD, Gearing M, Chin LS, and Li L. Oxidative modifications and down-regulation of ubiquitin carboxyl-terminal hydrolase L1 associated with idiopathic Parkinson's and Alzheimer's diseases. J Biol Chem 279: 13256-13264, 2004.
51. Choi J, Rees HD, Weintraub ST, Levey AI, Chin LS, and Li L. Oxidative modifications and aggregation of Cu,Znsuperoxide dismutase associated with Alzheimer and Parkinson diseases. J Biol Chem 280: 11648-11655, 2005.
52. Chueh PJ, Morre DM, Penel C, DeHahn T, and Morre DJ. The hormone-responsive NADH oxidase of the plant plasma membrane has properties of a NADH:protein disulfide reductase. J Biol Chem 272: 11221-11227, 1997.
53. Clutton P, Miermont A, and Freedman JE. Regulation of endogenous reactive oxygen species in platelets can reverse aggregation. Arterioscler Thromb Vasc Biol 24: 187-192, 2004.
54. Cohen Z, Davis-Gorman G, McDonagh PF, and Ritter L. Caspase inhibition of platelet activation. Blood Coagul Fibrinolysis 19: 305-309, 2008.
55. Coppinger JA, Cagney G, Toomey S, Kislinger T, Belton O, McRedmond JP, Cahill DJ, Emili A, Fitzgerald DJ, and Maguire PB. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103: 2096- 2104, 2004.
56. Cowan KJ, Law DA, and Phillips DR. Identification of shc as the primary protein binding to the tyrosinephosphorylated β 3 subunit of alpha IIbβ 3 during outsidein integrin platelet signaling. J Biol Chem 275: 36423-36429, 2000.
57. Croce K, Flaumenhaft R, Rivers M, Furie B, Furie BC, Herman IM, and Potter DA. Inhibition of calpain blocks platelet secretion, aggregation, and spreading. J Biol Chem 274: 36321-36327, 1999.
58. Dahlback B and Podack ER. Characterization of human S protein, an inhibitor of the membrane attack complex of complement. Demonstration of a free reactive thiol group. Biochemistry 24: 2368-2374, 1985.
59. Dalle-Donne I, Giustarini D, Colombo R, Milzani A, and Rossi R. S-glutathionylation in human platelets by a thioldisulfide exchange-independent mechanism. Free Radic Biol Med 38: 1501-1510, 2005.
60. Dalle-Donne I, Milzani A, Gagliano N, Colombo R, Giustarini D, and Rossi R. Molecular mechanisms and potential clinical significance of S-glutathionylation. Antioxid Redox Signal 10: 445-473, 2008.
61. Dallery N, Sablonniere B, Grillier I, Formstecher P, and DautrevauxM.Purification and functionalcharacterization of the ligand-binding domain from the retinoic acid receptor alpha: evidence that sulfhydryl groups are involved in ligandreceptor interactions. Biochemistry 32: 12428-12436, 1993.
62. Darby NJ, Penka E, and Vincentelli R. The multi-domain structure of protein disulfide isomerase is essential for high catalytic efficiency. J Mol Biol 276: 239-247, 1998.
63. de Boer HC, de Groot PG, Bouma BN, and Preissner KT. Ternary vitronectin-thrombin-antithrombin III complexes in human plasma. Detection and mode of association. J Biol Chem 268: 1279-1283, 1993.
64. Della Corte A, Maugeri N, Pampuch A, Cerletti C, de Gaetano G, and Rotilio D. Application of 2-dimensional difference gel electrophoresis (2D-DIGE) to the study of thrombin-activated human platelet secretome. Platelets 19: 43-50, 2008.
65. Deneke SM. Thiol-based antioxidants. Curr Top Cell Regul 36: 151-180, 2000.
66. Derrick JM, Shattil SJ, Poncz M, Gruppo RA, and Gartner TK. Distinct domains of αIIbβ3 support different aspects of outside-in signal transduction and platelet activation induced by LSARLAF, an αIIbβ3 interacting peptide. Thromb Haemost 86: 894-901, 2001.
67. Detwiler TC. Thiols and disulfides of thrombospondin. In: Thrombospondin, edited by Lahav J. Boca Raton, FL: CRC Press, 1993, p. 23-32.
68. Ding Z, Kim S, Dorsam RT, Jin J, and Kunapuli SP. Inactivation of the human P2Y12 receptor by thiol reagents requires interaction with both extracellular cysteine residues, Cys17 and Cys270. Blood 101: 3908-3914, 2003.
69. Dixit VM, Haverstick DM, O'Rourke KM, Hennessy SW, Grant GA, Santoro SA, and Frazier WA. A monoclonal antibody against human thrombospondin inhibits platelet aggregation. Proc Natl Acad Sci USA 82: 3472-3476, 1985.
70. Donoghue N and Hogg PJ. Identification of redox-active proteins on cell surface. Methods Enzymol 352: 101-112, 2002.
71. Donoghue N, Yam PT, Jiang XM, and Hogg PJ. Presence of closely spaced protein thiols on the surface of mammalian cells. Protein Sci 9: 2436-2445, 2000.
72. Dorsam RT and Kunapuli SP. Central role of the P2Y12 receptor in platelet activation. J Clin Invest 113: 340-345, 2004.
73. Doussiere J, Bouzidi F, Poinas A, Gaillard J, and Vignais PV. Kinetic study of the activation of the neutrophil NADPH oxidase by arachidonic acid. Antagonistic effects of arachidonic acid and phenylarsine oxide. Biochemistry 38: 16394-16406, 1999.
74. Droge W. Aging-related changes in the thiol/disulfide redox state: implications for the use of thiol antioxidants. Exp Gerontol 37: 1333-1345, 2002.
75. Eirin MT, Calvete JJ, and Gonzalez-Rodriguez J. New isolation procedure and further biochemical characterization of glycoproteins IIb and IIIa from human platelet plasma membrane. Biochem J 240: 147-153, 1986.
76. Elion J, Boissel JP, Le Bonniec B, Bezeaud A, Jandrot-Perrus M, Rabiet MJ, and Guillin MC. Proteolytic derivatives of thrombin. Ann NY Acad Sci 485: 16-26, 1986.
77. Ellgaard L and Ruddock LW. The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep 6: 28-32, 2005.
78. Emsley J, Knight CG, Farndale RW, Barnes MJ, and Liddington RC. Structural basis of collagen recognition by integrin α2β1. Cell 101: 47-56, 2000.
79. Era S, Kuwata K, Imai H, Nakamura K, Hayashi T, and Sogami M. Age-related change in redox state of human serum albumin. Biochim Biophys Acta 1247: 12-16, 1995.
80. Essex DW. The role of thiols and disulfides in platelet function. Antioxid Redox Signal 6: 736-746, 2004.
81. Essex DW, Chen K, and Swiatkowska M. Localization of protein disulfide isomerase to the external surface of the platelet plasma membrane. Blood 86: 2168-2173, 1995.
82. Essex DW and Li M. Protein disulphide isomerase mediates platelet aggregation and secretion. Br J Haematol 104: 448- 454, 1999.
83. Essex DW and Li M. Redox control of platelet aggregation. Biochemistry 42: 129-136, 2003.
84. Essex DW and Li M. Redox modification of platelet glycoproteins. Curr Drug Targets 7: 1233-1241, 2006.
85. Essex DW, Li M, Feinman RD, and Miller A. Platelet surface glutathione reductase-like activity. Blood 104: 1383- 1385, 2004.
86. Essex DW, Li M, Miller A, and Feinman RD. Protein disulfide isomerase and sulfhydryl-dependent pathways in platelet activation. Biochemistry 40: 6070-6075, 2001.
87. Essex DW, Miller A, Swiatkowska M, and Feinman RD. Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of vitronectin with thrombin-antithrombin. Biochemistry 38: 10398-10405, 1999.
88. Felding-Habermann B, O'Toole TE, Smith JW, Fransvea E, Ruggeri ZM, Ginsberg MH, Hughes PE, Pampori N, Shattil SJ, Saven A, and Mueller BM. Integrin activation controls metastasis in human breast cancer. Proc Natl Acad Sci USA 98: 1853-1858, 2001.
89. Fiaschi T, Cozzi G, Raugei G, Formigli L, Ramponi G, and Chiarugi P. Redox regulation of beta-actin during integrin-mediated cell adhesion. J Biol Chem 281: 22983- 22991, 2006.
90. Folts JD, Stamler J, and Loscalzo J. Intravenous nitroglycerin infusion inhibits cyclic blood flow responses caused by periodic platelet thrombus formation in stenosed canine coronary arteries. Circulation 83: 2122-2127, 1991.
91. Forman HJ, Fukuto JM, and Torres M. Redox signaling: thiol chemistry defines which reactive oxygen and nitrogen species can act as second messengers. Am J Physiol Cell Physiol 287: C246-256, 2004.
92. Fouchier F, Forget P, Pic P, Marvaldi J, and Pichon J. Modifications of the binding properties of the human VIP receptor of IGR39 cells by sulfhydryl reagents. Eur J Cell Biol 59: 382-388, 1992.
93. Fox JE. Cytoskeletal proteins and platelet signaling. Thromb Haemost 86: 198-213, 2001.
94. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, and Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 100: 350- 356, 1997.
95. Freedman JE, Loscalzo J, Benoit SE, Valeri CR, Barnard MR, and Michelson AD. Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest 97: 979-987, 1996.
96. Freedman JE, Sauter R, Battinelli EM, Ault K, Knowles C, Huang PL, and Loscalzo J. Deficient platelet-derived nitric oxide and enhanced hemostasis in mice lacking the NOSIII gene. Circ Res 84: 1416-1421, 1999.
97. Freedman JE, Ting B, Hankin B, Loscalzo J, Keaney JF, Jr., and Vita JA. Impaired platelet production of nitric oxide predicts presence of acute coronary syndromes. Circulation 98: 1481-1486, 1998.
98. Freedman RB, Klappa P, and Ruddock LW. Protein disulfide isomerases exploit synergy between catalytic and specific binding domains. EMBO Rep 3: 136-140, 2002.
99. Gallina A, Hanley TM, Mandel R, Trahey M, Broder CC, Viglianti GA, and Ryser HJ. Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptorbound glycoprotein 120 and prevent HIV-1 entry. J Biol Chem 277: 50579-50588, 2002.
100. Gambaryan S, Kobsar A, Hartmann S, Birschmann I, Kuhlencordt PJ, Muller-Esterl W, Lohmann SM, and Walter U. NO-synthase-/NO-independent regulation of human and murine platelet soluble guanylyl cyclase activity. J Thromb Haemost 6: 1376-1384, 2008.
101. Gertz M, Fischer F, Wolters D, and Steegborn C. Activation of the lifespan regulator p66Shc through reversible disulfide bond formation. Proc Natl Acad Sci USA 105: 5705- 5709, 2008.
102. Ghezzi P and Bonetto V. Redox proteomics: Identification of oxidatively modified proteins. Proteomics 3: 1145-1153, 2003.
103. Ghezzi P, Bonetto V, and Fratelli M. Thiol-disulfide balance: From the concept of oxidative stress to that of redox regulation. Antioxid Redox Signal 7: 964-972, 2005.
104. Giannoni E, Buricchi F, Raugei G, Ramponi G, and Chiarugi P. Intracellular reactive oxygen species activate Src tyrosine kinase during cell adhesion and anchoragedependent cell growth. Mol Cell Biol 25: 6391-6403, 2005.
105. Gilbert HF. Catalysis of thiol/disulfide exchange: Singleturnover reduction of protein disulfide-isomerase by glutathione and catalysis of peptide disulfide reduction. Biochemistry 28: 7298-7305, 1989.
106. Gilbert HF. Molecular and cellular aspects of thiol-disulfide exchange. Adv Enzymol Relat Areas Mol Biol 63: 69-172, 1990.
107. Gilbert HF. Protein disulfide isomerase and assisted protein folding. J Biol Chem 272: 29399-29402, 1997.
108. Gilbert HF. Thiol/disulfide exchange equilibria and disulfide bond stability. In: Methods in Enzymology. San Diego, CA: Academic Press, 1995, p. 8-30.
109. Giorgio M, Migliaccio E, Orsini F, Paolucci D, Moroni M, Contursi C, Pelliccia G, Luzi L, Minucci S, Marcaccio M, Pinton P, Rizzuto R, Bernardi P, Paolucci F, and Pelicci PG. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 122: 221-233, 2005.
110. Gitler C, Mogyoros M, and Kalef E. Labeling of protein vicinal dithiols: role of protein-S2 to protein-(SH)2 conversion in metabolic regulation and oxidative stress. Methods Enzymol 233: 403-415, 1994.
111. Gitler C, Zarmi B, and Kalef E. Use of cationic detergents to enhance reactivity of protein sulfhydryls. Methods Enzymol 251: 366-375, 1995.
112. Giustarini D, Campoccia G, Fanetti G, Rossi R, Giannerini F, Lusini L, and Di Simplicio P. Minor thiols cysteine and cysteinylglycine regulate the competition between glutathione and protein SH groups in human platelets subjected to oxidative stress. Arch Biochem Biophys 380: 1-10, 2000.
113. Giustarini D, Dalle-Donne I, Lorenzini S, Milzani A, and Rossi R. Age-related influence on thiol, disulfide, and protein-mixed disulfide levels in human plasma. J Gerontol A Biol Sci Med Sci 61: 1030-1038, 2006.
114. Giustarini D, Rossi R, Milzani A, Colombo R, and Dalle- Donne I. S-glutathionylation: from redox regulation of protein functions to human diseases. J Cell Mol Med 8: 201- 212, 2004.
115. Gkaliagkousi E, Ritter J, and Ferro A. Platelet-derived nitric oxide signaling and regulation. Circ Res 101: 654-662, 2007.
116. Handin RI, Karabin R, and Boxer GJ. Enhancement of platelet function by superoxide anion. J Clin Invest 59: 959- 965, 1977.
117. Harbury CB and Schrier SL. Modification of platelet sulfhydryl groups. Thromb Diath Haemorrh 31: 469-484, 1974.
118. Henn V, Slupsky JR, Grafe M, Anagnostopoulos I, Forster R, Muller-Berghaus G, and Kroczek RA. CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391: 591-594, 1998.
119. Hervig T, Mansoor MA, and Farstad M. Endogenous glutathione and platelet function in platelet concentrates stored in plasma or platelet additive solution. Transfus Med 11: 97-104, 2001.
120. Hess DT, Matsumoto A, Kim SO, Marshall HE, and Stamler JS. Protein S-nitrosylation: Purview and parameters. Nat Rev Mol Cell Biol 6: 150-166, 2005.
121. Hoffer LJ, Robitaille L, Elian KM, Bank I, Hongsprabhas P, and Mamer OA. Plasma reduced homocysteine concentrations are increased in end-stage renal disease. Kidney International 59: 372-377, 2001.
122. Hogg PJ, Hotchkiss KA, Jimenez BM, Stathakis P, and Chesterman CN. Interaction of platelet-derived growth factor with thrombospondin 1. Biochem J 326: 709-716, 1997.
123. Hotchkiss KA, Chesterman CN, and Hogg PJ. Catalysis of disulfide isomerization in thrombospondin 1 by protein disulfide isomerase. Biochemistry 35: 9761-9767, 1996.
124. Huang EM, Detwiler TC, Milev Y, and Essex DW. Thioldisulfide isomerization in thrombospondin: effects of conformation and protein disulfide isomerase. Blood 89: 3205- 3212, 1997.
125. Humphries MJ. Integrin structure. Biochem Soc Trans 28: 311-339, 2000.
126. Iafrati MD, Vitseva O, Tanriverdi K, Blair P, Rex S, Chakrabarti S, Varghese S, and Freedman JE. Compensatory mechanisms influence hemostasis in setting of eNOS deficiency. Am J Physiol Heart Circ Physiol 288: H1627-1632, 2005.
127. Jackson SP, Schoenwaelder SM, Yuan Y, Salem HH, and Cooray P. Non-receptor protein tyrosine kinases and phosphatases in human platelets. Thromb Haemost 76: 640- 650, 1996.
128. Jarvis GE, Atkinson BT, Snell DC, and Watson SP. Distinct roles of GPVI and integrin alpha(2)beta(1) in platelet shape change and aggregation induced by different collagens. Br J Pharmacol 137: 107-117, 2002.
129. Jauhiainen M, Stevenson KJ, and Dolphin PJ. Human plasma lecithin-cholesterol acyltransferase. The vicinal nature of cysteine 31 and cysteine 184 in the catalytic site. J Biol Chem 263: 6525-6533, 1988.
130. Jiang XM, Fitzgerald M, Grant CM, and Hogg PJ. Redox control of exofacial protein thiols/disulfides by protein disulfide isomerase. J Biol Chem 274: 2416-2423, 1999.
131. Joe PA, Banerjee A, and Luduena RF. The roles of cys124 and ser239 in the functional properties of human βIII tubulin. Cell Motil Cytoskeleton 65: 476-486, 2008.
132. Jones DP. Extracellular redox state: refining the definition of oxidative stress in aging. Rejuvenation Res 9: 169-181, 2006.
133. Jones DP. Redefining oxidative stress. Antioxid Redox Signal 8: 1865-1879, 2006.
134. Jordan PA, Stevens JM, Hubbard GP, Barrett NE, Sage T, Authi KS, and Gibbins JM. A role for the thiol isomerase protein ERP5 in platelet function. Blood 105: 1500-1507, 2005.
135. Kahner BN, Shankar H, Murugappan S, Prasad GL, and Kunapuli SP. Nucleotide receptor signaling in platelets. J Thromb Haemost 4: 2317-2326, 2006.
136. Kamata T, Ambo H, Puzon-McLaughlin W, Tieu KK, Handa M, Ikeda Y, and Takada Y. Critical cysteine residues for regulation of integrin αIIbβ3 are clustered in the epidermal growth factor domains of the β3 subunit. Biochem J 378: 1079-1082, 2004.
137. Kashiwagi A, Shinozaki K, Nishio Y, Maegawa H, Maeno Y, Kanazawa A, Kojima H, Haneda M, Hidaka H, Yasuda H, and Kikkawa R. Endothelium-specific activation of NAD(P)H oxidase in aortas of exogenously hyperinsulinemic rats. Am J Physiol 277: E976-983, 1999.
138. Kashiwagi H, Tomiyama Y, Tadokoro S, Honda S, Shiraga M, Mizutani H, Handa M, Kurata Y, Matsuzawa Y, and Shattil SJ. A mutation in the extracellular cysteine-rich repeat region of the β3 subunit activates integrins αIIbβ3 and αVβ3. Blood 93: 2559-2568, 1999.
139. Kasirer-Friede A, Cozzi MR, Mazzucato M, De Marco L, Ruggeri ZM, and Shattil SJ. Signaling through GP Ib-IX-V activates alpha IIb β 3 independently of other receptors. Blood 103: 3403-3411, 2004.
140. Kato M, Iwashita T, Takeda K, Akhand AA, Liu W, Yoshihara M, Asai N, Suzuki H, Takahashi M, and Nakashima I. Ultraviolet light induces redox reaction-mediated dimerization and superactivation of oncogenic Ret tyrosine kinases. Mol Biol Cell 11: 93-101, 2000.
141. Kim C, Crane FL, Faulk WP, and Morre DJ. Purification and characterization of a doxorubicin-inhibited NADH- quinone (NADH-ferricyanide) reductase from rat liver plasma membranes. J Biol Chem 277: 16441-16447, 2002.
142. Kim JH, Johannes L, Goud B, Antony C, Lingwood CA, Daneman R, and Grinstein S. Noninvasive measurement of the pH of the endoplasmic reticulum at rest and during calcium release. Proc Natl Acad Sci USA 95: 2997-3002, 1998.
143. Kim S, Foster C, Lecchi A, Quinton TM, Prosser DM, Jin J, Cattaneo M, and Kunapuli SP. Protease-activated receptors 1 and4donot stimulate G(i)signaling pathwaysinthe absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling. Blood 99: 3629-3636, 2002.
144. Knight CG, Morton LF, Onley DJ, Peachey AR, Messent AJ, Smethurst PA, Tuckwell DS, Farndale RW, and Barnes MJ. Identification in collagen type I of an integrin α2 β1-binding site containing an essential GER sequence. J Biol Chem 273: 33287-33294, 1998.
145. Knight CG, Morton LF, Peachey AR, Tuckwell DS, Farndale RW, and Barnes MJ. The collagen-binding A-domains of integrins alpha(1)beta(1) and alpha(2)beta(1) recognize the same specific amino acid sequence, GFOGER, in native (triple-helical) collagens. J Biol Chem 275: 35-40, 2000.
146. Kroll MH and Resendiz JC. Mechanisms of platelet activation. In: Thrombosis and Hemorrhage, edited by Loscalzo J and Schafer AI. Philadelphia, PA: Lippincott Williams & Wilkins, 2003, p. 187-205.
147. Krotz F, Riexinger T, Buerkle MA, Nithipatikom K, Gloe T, Sohn HY, Campbell WB, and Pohl U. Membrane-potentialdependent inhibition of platelet adhesion to endothelial cells by epoxyeicosatrienoic acids. Arterioscler Thromb Vasc Biol 24: 595-600, 2004.
148. Krotz F, Sohn HY, Gloe T, Zahler S, Riexinger T, Schiele TM, Becker BF, Theisen K, Klauss V, and Pohl U. NAD(P)H oxidase-dependent platelet superoxide anion release increases platelet recruitment. Blood 100: 917-924, 2002.
149. Krotz F, Sohn HY, and Pohl U. Reactive oxygen species: players in the platelet game. Arterioscler Thromb Vasc Biol 24: 1988-1996, 2004.
150. Kunapuli SP, Dorsam RT, Kim S, and Quinton TM. Platelet purinergic receptors. Curr Opin Pharmacol 3: 175-180, 2003.
151. Kutsumi H, Kawai K, Johnston RB, Jr., and Rokutan K. Evidence for participation of vicinal dithiols in the activation sequence of the respiratory burst of human neutrophils. Blood 85: 2559-2569, 1995.
152. Lahav J, Gofer-Dadosh N, Luboshitz J, Hess O, and Shaklai M. Protein disulfide isomerase mediates integrindependent adhesion. FEBS Lett 475: 89-92, 2000.
153. Lahav J, Jurk K, Hess O, Barnes MJ, Farndale RW, Luboshitz J, and Kehrel BE. Sustained integrin ligation involves extracellular free sulfhydryls and enzymatically catalyzed disulfide exchange. Blood 100: 2472-2478, 2002.
154. Lahav J, Wijnen EM, Hess O, Hamaia SW, Griffiths D, Makris M, Knight CG, Essex DW, and Farndale RW. Enzymatically catalyzed disulfide exchange is required for platelet adhesion to collagen via integrin α2β1. Blood 102: 2085-2092, 2003.
155. Landino LM, Iwig JS, Kennett KL, and Moynihan KL. Repair of peroxynitrite damage to tubulin by the thioredoxin reductase system. Free Radic Biol Med 36: 497-506, 2004.
156. Langenbach KJ and Sottile J. Identification of protein-disulfide isomerase activity in fibronectin. J Biol Chem 274: 7032-7038, 1999.
157. Laragione T, Bonetto V, Casoni F, Massignan T, Bianchi G, Gianazza E, and Ghezzi P. Redox regulation of surface protein thiols: identification of integrin alpha-4 as a molecular target by using redox proteomics. Proc Natl Acad Sci USA 100: 14737-14741, 2003.
158. Lash LH and Jones DP. Distribution of oxidized and reduced forms of glutathione and cysteine in rat plasma. Arch Biochem Biophys 240: 583-592, 1985.
159. Lassegue B and Clempus RE. Vascular NAD(P)H oxidases: Specific features, expression, and regulation. Am J Physiol Regul Integr Comp Physiol 285: R277-297, 2003.
160. Lauterburg BH and Velez ME. Glutathione deficiency in alcoholics: Risk factor for paracetamol hepatotoxicity. Gut 29: 1153-1157, 1988.
161. Le Cabec V and Maridonneau-Parini I. Complete and reversible inhibition of NADPH oxidase in human neutrophils by phenylarsine oxide at a step distal to membrane translocation of the enzyme subunits. J Biol Chem 270: 2067- 2073, 1995.
162. Lee SR, Kwon KS, Kim SR, and Rhee SG. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366-15372, 1998.
163. Leung LL. Role of thrombospondin in platelet aggregation. J Clin Invest 74: 1764-1772, 1984.
164. Li W, Mital S, Ojaimi C, Csiszar A, Kaley G, and Hintze TH. Premature death and age-related cardiac dysfunction in male eNOS-knockout mice. J Mol Cell Cardiol 37: 671-680, 2004.
165. Litvinov RI, Nagaswami C, Vilaire G, Shuman H, Bennett JS, and Weisel JW. Functional and structural correlations of individual αIIbβ3 molecules. Blood 104: 3979- 3985, 2004.
166. Liu Z, Rudd MA, Freedman JE, and Loscalzo J. S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide. J Pharmacol Exp Ther 284: 526-534, 1998.
167. Lopez JJ, Salido GM, Gomez-Arteta E, Rosado JA, and Pariente JA. Thrombin induces apoptotic events through the generation of reactive oxygen species in human platelets. J Thromb Haemost 5: 1283-1291, 2007.
168. Loscalzo J. N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest 76: 703- 708, 1985.
169. Loscalzo J. Nitric oxide insufficiency, platelet activation, and arterial thrombosis. Circ Res 88: 756-762, 2001.
170. Loscalzo J. Oxidant stress: A key determinant of atherothrombosis. Biochem Soc Trans 31: 1059-1061, 2003.
171. Low SY, Sabetkar M, Bruckdorfer KR, and Naseem KM. The role of protein nitration in the inhibition of platelet activation by peroxynitrite. FEBS Lett 511: 59-64, 2002.
172. Luo BH and Springer TA. Integrin structures and conformational signaling. Curr Opin Cell Biol 18: 579-586, 2006.
173. Luz JM and Lennarz WJ. Protein disulfide isomerase: a multifunctional protein of the endoplasmic reticulum. In: Stress-inducible cellular responses (1996 ed.), edited by Feige U, Morimoto RI, Yahara I and Polla B. Switzerland: Verlag Basel, 1996, p. 97-117.
174. MacIntyre DE and Gordon JL. Evidence for two populations of disulfide bonds on blood platelets. Biochem Soc Trans 2: 873-875, 1974.
175. 1. Biochem Soc Trans 2: 1265-1269, 1974.
176. MacIntyre DE, Grainge CA, Drummond AH, and Gordon JL. Effect of thio reagents on platelet transport processes and responses to stimuli. Biochem Pharmacol 26: 319-323, 1977.
177. Mancini F, Rigacci S, Berti A, Balduini C, and Torti M. The low-molecular-weight phosphotyrosine phosphatase is a negative regulator of FcgammaRIIA-mediated cell activation. Blood 110: 1871-1878, 2007.
178. Mandel R, Ryser HJ, Ghani F, Wu M, and Peak D. Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci USA 90: 4112-4116, 1993.
179. Manickam N, Sun X, Hakala KW, Weintraub ST, and Essex DW. Thiols in the αIIbβ3 integrin are necessary for platelet aggregation. Br J Haematol 142: 457-465, 2008.
180. Manickam N, Sun X, Li M, Gazitt Y, and Essex DW. Protein disulphide isomerase in platelet function. Br J Haematol 140: 223-229, 2008.
181. Mansoor MA, Svardal AM, and Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem 200: 218-229, 1992.
182. Marcus AJ, Silk ST, Safier LB, and Ullman HL. Superoxide production and reducing activity in human platelets. J Clin Invest 59: 149-158, 1977.
183. Marjanovic JA, Li Z, Stojanovic A, and Du X. Stimulatory roles of nitric-oxide synthase 3 and guanylyl cyclase in platelet activation. J Biol Chem 280: 37430-37438, 2005.
184. Martensson J. The effect of fasting on leukocyte and plasma glutathione and sulfur amino acid concentrations. Metabolism 35: 118-121, 1986.
185. Martinez-Ruiz A and Lamas S. Detection and proteomic identification of S-nitrosylated proteins in endothelial cells. Arch Biochem Biophys 423: 192-199, 2004.
186. Matsuda S, Ikeda Y, Aoki M, Toyama K, Watanabe K, and Ando Y. Role of reduced glutathione on platelet functions. Thromb Haemost 42: 1324-1331, 1979.
187. Matsushita K, Morrell CN, Mason RJ, Yamakuchi M, Khanday FA, Irani K, and Lowenstein CJ. Hydrogen peroxide regulation of endothelial exocytosis by inhibition of N-ethylmaleimide sensitive factor. J Cell Biol 170: 73-79, 2005.
188. Matthias LJ and Hogg PJ. Redox control on the cell surface: implications for HIV-1 entry. Antioxid Redox Signal 5: 133- 138, 2003.
189. Meister A. Glutathione Metabolism. In: Methods in Enzymology, edited by Packer L. San Diego, CA: Academic Press, 1995, p. 3-7.
190. Michelson AD, Benoit SE, Furman MI, Breckwoldt WL, Rohrer MJ, Barnard MR, and Loscalzo J. Effects of nitric oxide/EDRF on platelet surface glycoproteins. Am J Physiol 270: H1640-1648, 1996.
191. Milev Y and Essex DW. Protein disulfide isomerase catalyzes the formation of disulfide-linked complexes of thrombospondin-1 with thrombin-antithrombin III. Arch Biochem Biophys 361: 120-126, 1999.
192. Miller NR and Simons SS, Jr. Steroid binding to hepatoma tissue culture cell glucocorticoid receptors involves at least two sulfhydryl groups. J Biol Chem 263: 15217-15225, 1988.
193. Mor-Cohen R, Rosenberg N, Landau M, Lahav J, and Seligsohn U. Specific cysteines in {beta}3 are involved in disulfide bond exchange-dependent and -independent activation of {alpha}IIb{beta}3. J Biol Chem 283: 19235-19244, 2008.
194. Morla A, Zhang Z, and Ruoslahti E. Superfibronectin is a functionally distinct form of fibronectin. Nature 367: 193- 196, 1994.
195. Moro MA, Darley-Usmar VM, Goodwin DA, Read NG, Zamora-Pino R, Feelisch M, Radomski MW, and Moncada S. Paradoxical fate and biological action of peroxynitrite on human platelets. Proc Natl Acad Sci USA 91: 6702-6706, 1994.
196. Morre DJ and Morre DM. Cell surface NADH oxidases (ECTO-NOX proteins) with roles in cancer, cellular timekeeping, growth, aging and neurodegenerative diseases. Free Radic Res 37: 795-808, 2003.
197. Morrell CN, Matsushita K, Chiles K, Scharpf RB, Yamakuchi M, Mason RJ, Bergmeier W, Mankowski JL, Baldwin WM, 3rd, Faraday N, and Lowenstein CJ. Regulation of platelet granule exocytosis by S-nitrosylation. Proc Natl Acad Sci USA 102: 3782-3787, 2005.
198. Murugappa S and Kunapuli SP. The role of ADP receptors in platelet function. Front Biosci 11: 1977-1986, 2006.
199. Na HJ, Chung HT, Ha KS, Lee H, Kwon YG, Billiar TR, and Kim YM. Detection and measurement for the modification and inactivation of caspase by nitrosative stress in vitro and in vivo. Methods Enzymol 441: 317-327, 2008.
200. Nachman RL and Ferris B. Studies on the proteins of human platelet membranes. J Biol Chem 247: 4468-4475, 1972.
201. Nair S, Ghosh K, Kulkarni B, Shetty S, and Mohanty D. Glanzmann's thrombasthenia: updated. Platelets 13: 387- 393, 2002.
202. Najean Y and Rain JD. The mechanism of thrombocytopenia in patients with HIV infection. J Lab Clin Med 123: 415-420, 1994.
203. Nardi M, Feinmark SJ, Hu L, Li Z, and Karpatkin S. Complement-independent Ab-induced peroxide lysis of platelets requires 12-lipoxygenase and a platelet NADPH oxidase pathway. J Clin Invest 113: 973-980, 2004.
204. Nardi M, Tomlinson S, Greco MA, and Karpatkin S. Complement-independent, peroxide-induced antibody lysis of platelets in HIV-1-related immune thrombocytopenia. Cell 106: 551-561, 2001.
205. Nardi MA, Gor Y, Feinmark SJ, Xu F, and Karpatkin S. Platelet particle formation by anti GPIIIa49-66 Ab, Ca2+ ionophore A23187, and phorbol myristate acetate is induced by reactive oxygen species and inhibited by dexamethasone blockade of platelet phospholipase A2, 12- lipoxygenase, and NADPH oxidase. Blood 110: 1989-1996, 2007.
206. Naseem KM and Riba R. Unresolved roles of platelet nitric oxide synthase. J Thromb Haemost 6: 10-19, 2008.
207. Nitao LK, Yeates TO, and Reisler E. Conformational dynamics of the SH1-SH2 helix in the transition states of myosin subfragment-1. Biophys J 83: 2733-2741, 2002.
208. Noiva R. Protein disulfide isomerase: The multifunctional redox chaperone of the endoplasmic reticulum. Semin Cell Dev Biol 10: 481-493, 1999.
209. Nowak P, Olas B, Bald E, Glowacki R, and Wachowicz B. Peroxynitrite-induced changes of thiol groups in human blood platelets. Platelets 14: 375-379, 2003.
210. O'Neill S, Robinson A, Deering A, Ryan M, Fitzgerald DJ, and Moran N. The platelet integrin alpha IIbβ 3 has an endogenous thiol isomerase activity. J Biol Chem 275: 36984-36990, 2000.
211. Obergfell A, Eto K, Mocsai A, Buensuceso C, Moores SL, Brugge JS, Lowell CA, and Shattil SJ. Coordinate interactions of Csk, Src, and Syk kinases with [alpha]IIb[beta]3 initiate integrin signaling to the cytoskeleton. J Cell Biol 157: 265-275, 2002.
212. Oda M, Sakitani K, Kaibori M, Inoue T, Kamiyama Y, and Okumura T. Vicinal dithiol-binding agent, phenylarsine oxide, inhibits inducible nitric-oxide synthase gene expression at a step of nuclear factor-kappaB DNA binding in hepatocytes. J Biol Chem 275: 4369-4373, 2000.
213. Olas B and Wachowicz B. Role of reactive nitrogen species in blood platelet functions. Platelets 18: 555-565, 2007.
214. Ono A, Westein E, Hsiao S, Nesbitt WS, Hamilton JR, Schoenwaelder SM, and Jackson SP. Identification of a fibrin-independent platelet contractile mechanism regulating primary hemostasis and thrombus growth. Blood 112: 90- 99, 2008.
215. Ottaviano FG, Handy DE, and Loscalzo J. Redox regulation in the extracellular environment. Circ J 72: 1-16, 2008.
216. Pallis M, Grundy M, Turzanski J, Kofler R, and Russell N. Mitochondrial membrane sensitivity to depolarization in acute myeloblastic leukemia is associated with spontaneous in vitro apoptosis, wild-type TP53, and vicinal thiol/disulfide status. Blood 98: 405-413, 2001.
217. Parker CJ, Stone OL, White VF, and Bernshaw NJ. Vitronectin (S protein) is associated with platelets. Br J Haematol 71: 245-252, 1989.
218. Patel-Hett S, Richardson JL, Schulze H, Drabek K, Isaac NA, Hoffmeister K, Shivdasani RA, Bulinski JC, Galjart N, Hartwig JH, and Italiano JE, Jr. Visualization of microtubule growth in living platelets reveals a dynamic marginal band with multiple microtubules. Blood 111: 4605-4616, 2008.
219. Peerschke EI and Lopez JA. Platelet membranes and receptors. In: Thrombosis and Hemosrrhage. Philadelphia, PA: Lippincott Williams & Wilkins, 2003, p. 161-186.
220. Peerschke EIB and Lopez JA. Platelet membranes and receptors. In: Thrombosis and Hemorrhage (Second ed.), edited by Loscalzo J and Schafer AI. Baltimore: Williams & Wilkins, 1998, p. 229-260.
221. Pendurthi UR, Ghosh S, Mandal SK, and Rao LV. Tissue factor activation: is disulfide bond switching a regulatory mechanism? Blood 110: 3900-3908, 2007.
222. Pignatelli P, Pulcinelli FM, Lenti L, Gazzaniga PP, and Violi F. Hydrogen peroxide is involved in collagen-induced platelet activation. Blood 91: 484-490, 1998.
223. Pignatelli P, Sanguigni V, Lenti L, Ferro D, Finocchi A, Rossi P, and Violi F. gp91phox-dependent expression of platelet CD40 ligand. Circulation 110: 1326-1329, 2004.
224. Pirneskoski A, Klappa P, Lobell M, Williamson RA, Byrne L, Alanen HI, Salo KE, Kivirikko KI, Freedman RB, and Ruddock LW. Molecular characterization of the principal substrate binding site of the ubiquitous folding catalyst protein disulfide isomerase. J Biol Chem 279: 10374-10381, 2004.
225. Preissner KT, de Boer H, Pannekoek H, and de Groot PG. Thrombin regulation by physiological inhibitors: The role of vitronectin. Semin Thromb Hemost 22: 165-172, 1996.
226. Preissner KT, Wassmuth R, and Muller-Berghaus G. Physicochemical characterization of human S-protein and its function in the blood coagulation system. Biochem J 231: 349-355, 1985.
227. Qingqi Z and Stracher A. Platelet membrane actin may be partially embedded in lipid bilayer and disulfide linked. Biochem Biophys Res Commun 252: 407-411, 1998.
228. Ramachandran N, Root P, Jiang XM, Hogg PJ, and Mutus B. Mechanism of transfer of NO from extracellular S- nitrosothiols into the cytosol by cell-surface protein disulfide isomerase. Proc Natl Acad Sci USA 98: 9539-9544, 2001.
229. Raturi A, Miersch S, Hudson JW, and Mutus B. Platelet microparticle-associated protein disulfide isomerase promotes platelet aggregation and inactivates insulin. Biochim Biophys Acta 1778: 2790-2796, 2008.
230. Raturi A, Vacratsis PO, Seslija D, Lee L, and Mutus B. A direct, continuous, sensitive assay for protein disulphideisomerase based on fluorescence self-quenching. Biochem J 391: 351-357, 2005.
231. Reinhardt C, von Bruhl ML, Manukyan D, Grahl L, Lorenz M, Altmann B, Dlugai S, Hess S, Konrad I, Orschiedt L, Mackman N, Ruddock L, Massberg S, and Engelmann B. Protein disulfide isomerase acts as an injury response signal that enhances fibrin generation via tissue factor activation. J Clin Invest 118: 1110-1122, 2008.
232. Robey FA, Jamieson GA, and Hunt JB. Identification of four major classes of sulfhydryl groups in human blood platelets. Ferricyanide titration of spin-labeled platelets. J Biol Chem 254: 1010-1012, 1979.
233. Root P, Sliskovic I, and Mutus B. Platelet cell-surface protein disulphide-isomerase mediated S-nitrosoglutathione consumption. Biochem J 382: 575-580, 2004.
234. Ruggeri ZM. Platelets in atherothrombosis. Nat Med 8: 1227-1234, 2002.
235. Ruggeri ZM and Mendolicchio GL. Adhesion mechanisms in platelet function. Circ Res 100: 1673-1685, 2007.
236. Ruiz C, Liu CY, Sun QH, Sigaud-Fiks M, Fressinaud E, Muller JY, Nurden P, Nurden AT, Newman PJ, and Valentin N. A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb- IIIa (αIIbβ3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype. Blood 98: 2432-2441, 2001.
237. Ryser HJ, Levy EM, Mandel R, and DiSciullo GJ. Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci USA 91: 4559-4563, 1994.
238. Sahaf B, Heydari K, and Herzenberg LA. Lymphocyte surface thiol levels. Proc Natl Acad Sci USA 100: 4001-4005, 2003.
239. Salmeen A, Andersen JN, Myers MP, Meng TC, Hinks JA, Tonks NK, and Barford D. Redox regulation of protein tyrosine phosphatase 1B involves a sulphenyl-amide intermediate. Nature 423: 769-773, 2003.
240. Samanta AK, Dutta S, and Ali E. Modification of sulfhydryl groups of interleukin-8 (IL-8) receptor impairs binding of IL-8 and IL-8-mediated chemotactic response of human polymorphonuclear neutrophils. J Biol Chem 268: 6147- 6153, 1993.
241. Scharfstein JS, Keaney JF, Jr., Slivka A, Welch GN, Vita JA, Stamler JS, and Loscalzo J. In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest 94: 1432-1439, 1994.
242. Schmidt B, Ho L, and Hogg PJ. Allosteric disulfide bonds. Biochemistry 45: 7429-7433, 2006.
243. Seiffert D and Schleef RR. Two functionally distinct pools of vitronectin (Vn) in the blood circulation: Identification of a heparin-binding competent population of Vn within platelet alpha-granules. Blood 88: 552-560, 1996.
244. Sen CK. Redox signaling and the emerging therapeutic potential of thiol antioxidants. Biochem Pharmacol 55: 1747- 1758, 1998.
245. Sengupta S, Chen H, Togawa T, DiBello PM, Majors AK, Budy B, Ketterer ME, and Jacobsen DW. Albumin thiolate anion is an intermediate in the formation of albumin-S-S- homocysteine. J Biol Chem 276: 30111-30117, 2001.
246. Seno T, Inoue N, Gao D, Okuda M, Sumi Y, Matsui K, Yamada S, Hirata KI, Kawashima S, Tawa R, Imajoh-Ohmi S, Sakurai H, and Yokoyama M. Involvement of NADH/NADPH oxidase in human platelet ROS production. Thromb Res 103: 399-409, 2001.
247. Sevier CS and Kaiser CA. Formation and transfer of disulphide bonds in living cells. Nat Rev Mol Cell Biol 3: 836- 847, 2002.
248. Shah CM, Bell SE, Locke IC, Chowdrey HS, and Gordge MP. Interactions between cell surface protein disulphide isomerase and S-nitrosoglutathione during nitric oxide delivery. Nitric Oxide 16: 135-142, 2007.
249. Shattil SJ, Kashiwagi H, and Pampori N. Integrin signaling: The platelet paradigm. Blood 91: 2645-2657, 1998.
250. Shattil SJ and Newman PJ. Integrins: dynamic scaffolds for adhesion and signaling in platelets. Blood 104: 1606-1615, 2004.
251. Simon DI, Stamler JS, Loh E, Loscalzo J, Francis SA, and Creager MA. Effect of nitric oxide synthase inhibition on bleeding time in humans. J Cardiovasc Pharmacol 26: 339- 342, 1995.
252. Soslau G, Class R, Morgan DA, Foster C, Lord ST, Marchese P, and Ruggeri ZM. Unique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib. J Biol Chem 276: 21173-21183, 2001.
253. Spangenberg P, Till U, Gschmeissner S, and Crawford N. Changes in the distribution and organization of platelet actin induced by diamide and its functional consequences. Br J Haematol 67: 443-450, 1987.
254. Speziale MV and Detwiler TC. Free thiols of platelet thrombospondin. Evidence for disulfide isomerization. J Biol Chem 265: 17859-17867, 1990.
255. Stamler J, Mendelsohn ME, Amarante P, Smick D, Andon N, Davies PF, Cooke JP, and Loscalzo J. N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res 65: 789-795, 1989.
256. Stamler JS, Jaraki O, Osborne J, Simon DI, Keaney J, Vita J, Singel D, Valeri CR, and Loscalzo J. Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci USA 89: 7674-7677, 1992.
257. Sugatani J, Steinhelper ME, Saito K, Olson MS, and Hanahan DJ. Potential involvement of vicinal sulfhydryls in stimulus-induced rabbit platelet activation. J Biol Chem 262: 16995-17001, 1987.
258. Sullam PM, Hyun WC, Szollosi J, Dong J, Foss WM, and Lopez JA. Physical proximity and functional interplay of the glycoprotein Ib-IX-V complex and the Fc receptor FcgammaRIIA on the platelet plasma membrane. J Biol Chem 273: 5331-5336, 1998.
259. Sun QH, Liu CY, Wang R, Paddock C, and Newman PJ. Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes. Blood 100: 2094-2101, 2002.
260. Sun XZ, Vinci C, Makmura L, Han S, Tran D, Nguyen J, Hamann M, Grazziani S, Sheppard S, Gutova M, Zhou F, Thomas J, and Momand J. Formation of disulfide bond in p53 correlates with inhibition of DNA binding and tetramerization. Antioxid Redox Signal 5: 655-665, 2003.
261. Swiatkowska M, Szymanski J, Padula G, and Cierniewski CS. Interaction and functional association of protein disulfide isomerase with alpha(V)beta(3) integrin on endothelial cells. FEBS J 275: 1813-1823, 2008.
262. Switalska HI, Niewiarowski S, Tuszynski GP, Rucinski B, Schmaier AH, Morinelli TA, and Cierniewski CS. Radioimmunoassay of human platelet thrombospondin: different patterns of thrombospondin and beta-thromboglobulin antigen secretion and clearance from the circulation. J Lab Clin Med 106: 690-700, 1985.
263. Tajima M and Sakagami H. Tetrahydrobiopterin impairs the action of endothelial nitric oxide via superoxide derived from platelets. Br J Pharmacol 131: 958-964, 2000.
264. Takagi J. Structural basis for ligand recognition by integrins. Curr Opin Cell Biol 19: 557-564, 2007.
265. Takagi J, Beglova N, Yalamanchili P, Blacklow SC, and Springer TA. Definition of EGF-like, closely interacting modules that bear activation epitopes in integrin β subunits. Proc Natl Acad Sci USA 98: 11175-11180, 2001.
266. Takagi J, Petre BM, Walz T, and Springer TA. Global conformational rearrangements in integrin extracellular domains in outside-in and inside-out signaling. Cell 110: 599- 511, 2002.
267. Takagi J and Springer TA. Integrin activation and structural rearrangement. Immunol Rev 186: 141-163, 2002.
268. Thai le M, Ashman LK, Harbour SN, Hogarth PM, and Jackson DE. Physical proximity and functional interplay of PECAM-1 with the Fc receptor Fc gamma RIIa on the platelet plasma membrane. Blood 102: 3637-3645, 2003.
269. Thiagarajan P and Kelly KL. Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem 263: 3035-3038, 1988.
270. Titani K, Takio K, Handa M, and Ruggeri ZM. Amino acid sequence of the von Willebrand factor-binding domain of platelet membrane glycoprotein Ib. Proc Natl Acad Sci USA 84: 5610-5614, 1987.
271. Tomasini BR and Mosher DF. Conformational states of vitronectin: preferential expression of an antigenic epitope when vitronectin is covalently and noncovalently complexed with thrombin-antithrombin III or treated with urea. Blood 72: 903-912, 1988.
272. Tomasini BR, Owen MC, Fenton JW, 2nd, and Mosher DF. Conformational lability of vitronectin: induction of an antigenic change by alpha-thrombin-serpin complexes and by proteolytically modified thrombin. Biochemistry 28: 7617- 7623, 1989.
273. Torchinsky YM. Sulfur in Proteins. New York: Pergamon Press, 1981.
274. Turano C, Coppari S, Altieri F, and Ferraro A. Proteins of the PDI family: unpredicted non-ER locations and functions. J Cell Physiol 193: 154-163, 2002.
275. Uehara T, Nakamura T, Yao D, Shi ZQ, Gu Z, Ma Y, Masliah E, Nomura Y, and Lipton SA. S-nitrosylated proteindisulphide isomerase links protein misfolding to neurodegeneration. Nature 441: 513-517, 2006.
276. Ueland PM, Mansoor MA, Guttormsen AB, Muller F, Aukrust P, Refsum H, and Svardal AM. Reduced, oxidized and protein-bound forms of homocysteine and other aminothiols in plasma comprise the redox thiol status-a possible element of the extracellular antioxidant defense system. J Nutr 126: 1281S-1284S, 1996.
277. Varga-Szabo D, Pleines I, and Nieswandt B. Cell adhesion mechanisms in platelets. Arterioscler Thromb Vasc Biol 28: 403-412, 2008.
278. Walsh GM, Leane D, Moran N, Keyes TE, Forster RJ, Kenny D, and O'Neill S. S-Nitrosylation of platelet αIIbβ3 as revealed by Raman spectroscopy. Biochemistry 46: 6429-6436, 2007.
279. Wang J, Boja ES, Tan W, Tekle E, Fales HM, English S, Mieyal JJ, and Chock PB. Reversible glutathionylation regulates actin polymerization in A431 cells. J Biol Chem 276: 47763-47766, 2001.
280. Wang JP, Tsai JJ, Chen YS, and Hsu MF. Stimulation of intracellular Ca2+ elevation in neutrophils by thioloxidizing phenylarsine oxide. Biochem Pharmacol 69: 1225- 1234, 2005.
281. Winter J, Klappa P, Freedman RB, Lilie H, and Rudolph R. Catalytic activity and chaperone function of human protein-disulfide isomerase are required for the efficient refolding of proinsulin. J Biol Chem 277: 310-317, 2002.
282. Wolfs JL, Wielders SJ, Comfurius P, Lindhout T, Giddings JC, Zwaal RF, and Bevers EM. Reversible inhibition of the platelet procoagulant response through manipulation of the Gardos channel. Blood 108: 2223-2228, 2006.
283. Wolin MS, Gupte SA, and Oeckler RA. Superoxide in the vascular system. J Vasc Res 39: 191-207, 2002.
284. Wolvetang EJ, Larm JA, Moutsoulas P, and Lawen A. Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin. Cell Growth Differ 7: 1315-1325, 1996.
285. Xiao T, Takagi J, Coller BS, Wang JH, and Springer TA. Structural basis for allostery in integrins and binding to fibrinogen-mimetic therapeutics. Nature 432: 59-67, 2004.
286. Xiong JP, Stehle T, Diefenbach B, Zhang R, Dunker R, Scott DL, Joachimiak A, Goodman SL, and Arnaout MA. Crystal structure of the extracellular segment of integrin alpha Vβ3. Science 294: 339-345, 2001.
287. Xiong JP, Stehle T, Goodman SL, and Arnaout MA. New insights into the structural basis of integrin activation. Blood 102: 1155-1159, 2003.
288. Yan B and Smith JW. Mechanism of integrin activation by disulfide bond reduction. Biochemistry 40: 8861-8867, 2001.
289. Yan B and Smith JW. A redox site involved in integrin activation. J Biol Chem 275: 39964-39972, 2000.
290. Yin K, Lai PS, Rodriguez A, Spur BW, and Wong PY. Antithrombotic effects of peroxynitrite: inhibition and reversal of aggregation in human platelets. Prostaglandins 50: 169-178, 1995.
291. Zai A, Rudd MA, Scribner AW, and Loscalzo J. Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest 103: 393-399, 1999.
292. Zang Q and Springer TA. Amino acid residues in the PSI domain and cysteine-rich repeats of the integrin β2 subunit that restrain activation of the integrin alpha(X)beta(2). J Biol Chem 276: 6922-6929, 2001.
293. Zhang L and Aggarwal BB. Role of sulfhydryl groups in induction of cell surface down-modulation and shedding of extracellular domain of human TNF receptors in human histiocytic lymphoma U937 cells. J Immunol 153: 3745-3754, 1994.
294. Zucker MB and Masiello NC. Platelet aggregation caused by dithiothreitol. Thromb Haemost 51: 119-124, 1984.